Genalyte

San Diego, United States Founded: 2007 • Age: 19 yrs
Silicon photonics-based multiplexing tools for biomolecular detection are developed.

About Genalyte

Genalyte is a company based in San Diego (United States) founded in 2007.. Genalyte has raised $141.8 million across 7 funding rounds from investors including Samsara, Verily and Khosla Ventures. The company has 113 employees as of December 31, 2022. Genalyte has completed 1 acquisition, including BaseHealth. Genalyte offers products and services including Merlin. Genalyte operates in a competitive market with competitors including Enumera Molecular, Lyfas, Attomarker, Adsys and Kanichi Research Services, among others.

  • Headquarter San Diego, United States
  • Employees 113 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Genalyte, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $141.8 M (USD)

    in 7 rounds

  • Latest Funding Round
    $50 M (USD), Series E

    Jan 11, 2021

  • Investors
    Samsara

    & 11 more

  • Employee Count
    113

    as on Dec 31, 2022

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Genalyte

Genalyte offers a comprehensive portfolio of products and services, including Merlin. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for rapid automated lab testing with real-time results.

People of Genalyte
Headcount 50-200
Employee Profiles 27
Board Members and Advisors 6
Employee Profiles
People
Nikki Davis
Director, Laboratory Operations
People
Ashraf Hanna
Chief Executive Officer
People
Lewis Marshall
Senior Director Of Hardware Engineering
People
Rufus Burlingame
VP Clinical Assay Development

Unlock access to complete

Board Members and Advisors
people
Jeff Huber
Chairman
people
Saeid Akhtari
Board Member
people
Rami El Assal
Director

Unlock access to complete

Funding Insights of Genalyte

Genalyte has successfully raised a total of $141.8M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $50 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series E — $50.0M
  • First Round

    (30 Mar 2012)

  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2021 Amount Series E - Genalyte Valuation Verily
Nov, 2016 Amount Series D - Genalyte Valuation Khosla Ventures , Redmile Group
Aug, 2015 Amount Series C - Genalyte Valuation Khosla Ventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Genalyte

Genalyte has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Samsara, Verily and Khosla Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early-stage startups are funded by this venture capital firm.
Founded Year Domain Location
Late-stage life sciences investments are managed via VC and PE.
Founded Year Domain Location
Seed and early-stage venture capital firm investing in digital solutions for healthcare and energy industries.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Genalyte

Genalyte has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BaseHealth. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Genomics-driven personalized health risks and recommendations are provided.
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Genalyte

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genalyte Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Genalyte

Genalyte operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enumera Molecular, Lyfas, Attomarker, Adsys and Kanichi Research Services, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Liquid biopsy tools are developed for biomolecule assessment.
domain founded_year HQ Location
Provider of AI-based predictive and preventive digital health test and home remedy
domain founded_year HQ Location
Provider of at-home Covid diagnostic testing services
domain founded_year HQ Location
Provider of AI-based device for rapid blood diagnosis
domain founded_year HQ Location
Develops sensors for medical diagnosis through breath analysis.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genalyte

Frequently Asked Questions about Genalyte

When was Genalyte founded?

Genalyte was founded in 2007 and raised its 1st funding round 5 years after it was founded.

Where is Genalyte located?

Genalyte is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Is Genalyte a funded company?

Genalyte is a funded company, having raised a total of $141.8M across 7 funding rounds to date. The company's 1st funding round was a Series C of $44M, raised on Mar 30, 2012.

How many employees does Genalyte have?

As of Dec 31, 2022, the latest employee count at Genalyte is 113.

What does Genalyte do?

Genalyte was founded in 2007 in San Diego, United States, focusing on biotechnology for clinical and life science applications. Next-generation multiplexing technology is developed and commercialized, utilizing silicon chip manufacturing for immunodetection. The Maverick platform employs silicon photonics to measure antibody-antigen binding and nucleic acid hybridization. Instruments support autoimmune disease monitoring, cancer biomarker screening, infectious agent testing, and anti-drug antibody detection, with the first launch occurring in 2012.

Who are the top competitors of Genalyte?

Genalyte's top competitors include Lyfas, Attomarker and Adsys.

What products or services does Genalyte offer?

Genalyte offers Merlin.

How many acquisitions has Genalyte made?

Genalyte has made 1 acquisition, including BaseHealth.

Who are Genalyte's investors?

Genalyte has 12 investors. Key investors include Samsara, Verily, Khosla Ventures, HHS, and National Cancer Institute.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available